You are here

  • Home
  • Online First
  • Esmolol: a viable option for current antinociceptive clinical research

Article Text

Article menu

other Versions

Download PDFPDF
PostScript
Letter to the editor
Esmolol: a viable option for current antinociceptive clinical research

https://doi.org/10.1136/rapm-2019-100450

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    You do not have access to the full text of this article, the first page of the PDF of this article appears above.

    Footnotes

    • Contributors BW is the sole author in this reply to a letter to the editor.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Commissioned; internally peer reviewed.